2019 Archive

Outreach

Psychology’s 10th anniversary: Department chair remembers modest beginnings, remarkable growth

Sean Phipps, PhD

Learn how psychologists use their clinical and research expertise to help children with cancer and other life-threatening diseases.

Outreach

The St. Jude School Program’s new principal has learned a thing or two

Barry Wolverton

It’s difficult to do school when you’re fighting cancer, but this new approach to learning may make learning fun again for cancer patients.

Research

Pediatric immunotherapy: How two immunologists are paving the way for improved treatments

Caleigh Morr

Two friends and research colleagues are looking at different stages of the immune response to pave the way for enhanced cancer treatments.

Investigator Insights

How my global journey led to St. Jude

Shaloo Puri, MD

An early dream of being an astronaut planted the seeds of exploration and making a difference in this college dean.

Outreach

Postdoc mentoring: How one lab created a culture of support and success

Caleigh Morr

A researcher who works with their lab members accomplish more than he or she ever could alone. Learn how Dr. Mark Hatley mentors his postdocs.

Clinical

A not-so-bitter pill to swallow

Keith Crabtree, PhD

Pill swallowing should be easy – imagine the stress when the pills are life-saving and you have a physical condition that makes it difficult – what then?

Clinical

New chemotherapies change the paradigm of cancer treatment

Arijit Basu

New treatments have led to new thinking and new approaches to pediatric cancer – and sometimes, a cure isn’t the goal.

Research

Lando: Star Wars smuggler or possible ally against Alzheimer’s disease?

Mary Powers

High science calls on Star Wars character as a potential ally against Alzheimer’s disease.

Research

SJELIOT clinical trial explores a new approach for recurring and unresponsive medulloblastoma tumors

Gary Bridgman

St. Jude is testing adult cancer drug prexasertib in children with recurrent or refractory medulloblastoma to inhibit checkpoint kinase chk1/2.

Investigator Insights

The 17 Samurai

Hiroto Inaba, MD, PhD

Hiroto Inaba: scientist, pediatric oncologist and "first son" of an old samurai family. His unfortunate enemy: childhood cancer.